Weekly shot could replace daily HIV pill cocktail
NCT ID NCT02355184
Summary
This extension study tested whether weekly PRO140 injections alone could maintain HIV suppression long-term in people who successfully switched from standard combination therapy. The trial enrolled 20 adults who had already completed 12 weeks of PRO140 treatment without their virus rebounding. Participants received weekly injections and were closely monitored for viral rebound, with the option to restart their original therapy if needed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CD01-Extension Investigational Site
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.